Adma Biologics (ADMA) closed the most recent trading day at $9.16, moving +2.35% from the previous trading session. The stock ...

Adma Biologics (ADMA) closed at $8.37 in the latest trading session, marking a -4.34% move from the prior day.

These stocks are better bets to skyrocket than the much-hyped rocket stock.

If you have suffered a loss on your ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at [email prot ...

On Thursday, California-based Palisades Investment Partners disclosed a complete exit from ADMA Biologics (NASDAQ:ADMA), selling 398,647 shares for an estimated $7.3 million. According to a filing ...

Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of $40 Million in 4Q 2025 2026 Expected to be ADMA's First Full Year of Yield-Enhanced Production, ...

Key Points Interested in Vera Therapeutics, Inc.? Here are five stocks we like better. For biopharma companies, a huge amount ...

In the latest trading session, Adma Biologics (ADMA) closed at $8.69, marking a +1.4% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.44%. Elsewhere, the Dow ...

The MarketWatch News Department was not involved in the creation of this content. Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business ...

Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options. About the Lawsuit ADMA and certain of its executives are charged with failing to disclose material information during the ...